Literature DB >> 22044772

Non-invasive assessment of liver fibrosis in patients after the Fontan operation.

Takeshi Furukawa1, Katsumi Akimoto, Masahiro Ohtsuki, Keiko Sato, Mitsuyoshi Suzuki, Ken Takahashi, Masahiko Kishiro, Toshiaki Shimizu, Shiori Kawasaki.   

Abstract

BACKGROUND: This study analyzed the change in liver fibrosis markers after the Fontan operation and investigated their clinical usefulness as an index of congestive liver fibrosis.
METHODS: The study enrolled 24 patients who underwent the Fontan operation between January 1994 and December 2008. We subdivided the postoperative period into four intervals and then compared the hepatological markers during each. Eighteen patients underwent postoperative cardiac catheterization and the correlation between hepatological markers and the inferior vena cava (IVC) pressure was analyzed.
RESULTS: The mean age of the patients was 138.6 months and the mean interval between the Fontan operation and the examination was 97.8 months. Type IV collagen was extremely high in every interval (I, 286 ± 93; II, 265 ± 93; III, 305 ± 143; IV, 206 ± 70), while none of the laboratory variables changed significantly in each interval. A significant positive correlation was observed between type IV collagen and the IVC pressure, but no significant correlation with any other hepatological marker was detected.
CONCLUSIONS: No specific parameter that reflects the progress in liver fibrosis was identified in this study. The possibility exists that type IV collagen reflects the degree of hepatic congestion.
© 2011 The Authors. Pediatrics International © 2011 Japan Pediatric Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22044772     DOI: 10.1111/j.1442-200X.2011.03497.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  7 in total

1.  Liver Strain Using Feature Tracking of Cine Cardiac Magnetic Resonance Imaging: Assessment of Liver Dysfunction in Patients with Fontan Circulation and Tetralogy of Fallot.

Authors:  Ryoko Ohashi; Michinobu Nagao; Umiko Ishizaki; Yumi Shiina; Kei Inai; Shuji Sakai
Journal:  Pediatr Cardiol       Date:  2019-12-18       Impact factor: 1.655

2.  Serial evaluation of hepatic function profile after Fontan operation.

Authors:  R Kaulitz; P Haber; E Sturm; J Schäfer; M Hofbeck
Journal:  Herz       Date:  2013-05-08       Impact factor: 1.443

3.  Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening.

Authors:  T Ackerman; A Geerts; H Van Vlierberghe; J De Backer; K François
Journal:  Pediatr Cardiol       Date:  2018-07-21       Impact factor: 1.655

4.  Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function.

Authors:  Kathleen E Simpson; Amir Esmaeeli; Geetika Khanna; Francis White; Yumirle Turnmelle; Pirooz Eghtesady; Umar Boston; Charles E Canter
Journal:  J Heart Lung Transplant       Date:  2013-10-25       Impact factor: 10.247

5.  Fontan Liver Disease: Review of an Emerging Epidemic and Management Options.

Authors:  Elisa Bradley; Benjamin Hendrickson; Curt Daniels
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-11

6.  Serum hyaluronic acid concentration in Fontan circulation: correlation with hepatic function and portal vein hemodynamics.

Authors:  Taiyu Hayashi; Ryo Inuzuka; Takahiro Shindo; Yoichiro Hirata; Nobutaka Shimizu; Akira Oka
Journal:  Pediatr Cardiol       Date:  2013-10-26       Impact factor: 1.655

7.  Fontan-Associated Liver Disease: Spectrum of Disease in Children and Adolescents.

Authors:  Steven L Rathgeber; Orlee R Guttman; Anna F Lee; Christine Voss; Nicole M Hemphill; Richard A Schreiber; Kevin C Harris
Journal:  J Am Heart Assoc       Date:  2020-01-04       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.